OOS Investigation Checklist (Free, PDF/Excel)

0%

0 of 37 items complete

15 critical items still open - these are the highest-risk gaps.

Download checklist:

Immediate response (analyst and supervisor)

Stop and report the suspect result to the supervisor without discarding anythingCRITICALRetain all solutions, standards, sample preparations, vials and glassware as foundCRITICALRecord the result and time in the raw data; do not delete, overwrite or re-inject to see a better valueCRITICALOpen an OOS number in the register and notify QA the same dayConfirm the product, batch, test, specification and method version are correctly identifiedSecure the raw data, chromatograms, balance printouts and instrument logs

Phase I: laboratory assessment

Check calculations, dilutions, sample weights and units against raw dataCRITICALVerify the instrument was calibrated, qualified and had passed system suitabilityCRITICALCheck standard and reagent identity, grade, potency, preparation date and expiryCheck the analyst training record for this methodReview the audit trail for the run for deleted, reprocessed or manually integrated dataCRITICALCheck sample storage, handling, container and time between sampling and testingInterview the analyst without assigning blame and record observationsCheck the method was followed exactly, including column, mobile phase, temperature and timingDocument whether an assignable laboratory error was found and its evidenceCRITICAL

Retesting and resampling rules

Retest only after an assignable cause is documented or per the approved retest protocolCRITICALDefine in advance the number of retests and who performs them, not the same analyst aloneDo not average a failing result with passing results to hide the failureCRITICALDo not test into compliance by repeating until a passing result appearsCRITICALUse the original homogeneous sample or retained sample, and document the amount usedResample only when sampling error is documented and justifiedTreat all valid results, including the original, as reportable unless invalidated with evidence

Phase II: full-scale investigation (production and QC)

Extend the review to the manufacturing batch record, process parameters and deviationsCRITICALReview raw materials, equipment, cleaning, environment and operator actions for the batchCheck other batches and products made on the same equipment or with the same lot of materialCRITICALReview historical OOS and trend data for the same test and productRun additional testing under a written protocol approved by QA before it startsUse a structured tool such as a fishbone or 5 Whys and record the root cause or probable causeAssess impact on stability studies, released batches and marketed productCRITICALConsider a field alert or regulatory notification if distributed product is affected

Conclusion, disposition and closure

State a clear conclusion: invalidated with assignable cause, or confirmed OOSCRITICALDisposition of the batch (release, rework, reject) documented and approved by QACRITICALCorrective and preventive actions defined with owners and datesLink the OOS to any deviation, CAPA or change control numbersUpdate the trending record and the OOS logComplete the investigation within the time set by your SOP (commonly 30 working days)QA head signs the final report

Every critical item must be ticked before the OOS report is closed. Phase I does not end with a retest unless a lab error is proven. Based on the structure of FDA guidance on investigating out of specification results (2006) and EU GMP Chapter 6, but your own SOP governs.

OOS history and related batches from ERP data

An optional outline for finding related batches and equipment history when an OOS is opened.

Optional. The tool and every export work without this. No spam.

How to use the checklist

Work through the groups in order. Start the first group the moment a suspect result is seen, before any retest. Tick items as you complete them, and keep a note of where the evidence is, such as the notebook page or the audit trail ID. Export the checklist to PDF to attach to the investigation report. The critical items are the ones inspectors most often cite as failures, so none should remain open at closure.

Do not retest before Phase I is done
Never discard the original preparations
Involve QA from the first day
Keep a single OOS number from start to end

Phase I and Phase II

Phase I is the laboratory assessment, led by the analyst and supervisor, looking for obvious errors in calculation, instrument, standard or method execution. If a clear assignable cause is found and documented, the original result may be invalidated and a retest performed. If not, the investigation moves to Phase II, which is a full-scale investigation involving production, QA and possibly other batches. The FDA 2006 guidance sets out this structure.

Retesting without testing into compliance

The retest plan must be written before testing, with a fixed number of retests and rules for evaluating them. Repeating a test until it passes and ignoring the failing results is considered testing into compliance and is a data integrity violation. Averaging is acceptable only when averaging is the method's defined reporting rule. All results, valid and invalid, stay in the records with the reason for any invalidation.

Common mistakes and systems notes

Findings often cite informal retesting, late QA notification, missing audit trail review, investigation that ignores other batches and root cause stated only as analyst error. In LIMS and ERP quality modules, place the batch on quality hold when the OOS is registered. OOT (out of trend) results, which are inside the specification but atypical, need their own procedure but benefit from the same discipline.

Frequently Asked Questions

What is the difference between OOS and OOT?

An OOS result is outside the registered or approved specification. An OOT result is within specification but outside the expected trend, for example a stability result dropping faster than earlier lots. OOT is an early warning and should trigger a review.

Can I retest an OOS sample immediately?

Not before documenting why. A retest is justified when a laboratory error is confirmed or when the approved SOP defines a retest plan. Immediate unplanned repeating is a classic data integrity finding.

How long should an OOS investigation take?

Many SOPs set 30 working days for closure, with the FDA expecting investigations to be timely and documented. Extensions need written justification, and the batch stays on hold while the investigation is open.

Can an OOS be invalidated?

Yes, only when a documented, verified laboratory error is found as the assignable cause. Suspicion alone, or a later passing result, does not invalidate a failing result.

Netray can help build a private assistant that checks LIMS and ERP data for related batches when an OOS is opened. The checklist works fully on its own.

Talk to an Expert Explore More Free Tools

Related Tools

Quality & Inspection

More Quality & Inspection tools

See all

OOS Investigation Checklist for GMP QC Laboratories